Suryaprakash Sambhara is a Section Chief of immunology, IPB, in the Influenza Division at the Centers for Disease Control and Prevention in Atlanta, Ga, USA. He serves also as an Adjunct Faculty Member at Georgia State University and Purdue University. He received his D.V.M. degree in 1977 and M.V.S. degree in 1980 from the College of Veterinary Science, A.P. Agricultural University, an M.S. degree in 1986 from the University of Wyoming, and a Ph.D. degree in immunology from the University of Toronto. He pursued his Ph.D. degree in Rick Miller’s laboratory working on peripheral T-cell tolerance mechanisms and collaborated with Tak Mak on the generation and characterization of CD4 gene knockout as well as TCR-transgenic mouse. From 1992-2000, he served as a Research Scientist as well as a Section Head of immunology in the Research and Development Division at Aventis Pasteur, now Sanofi Pasteur, Toronto, ON, Canada where his research focused on improving influenza vaccine, developing RSV vaccine (subunit and DNA), therapeutic vaccines for melanoma and colorectal cancer, setting up human immunology platform and developing animal models of human disease. After about 9 years at Sanofi Pasteur, managing several research scientists, technologists, and programs, he moved to CDC in 2000 to set up immunobiology of aging, vaccine development, innate and adaptive immunity to influenza, and human immunology programs. Dr. Sambhara’s research interests include vaccine development, adjuvants and formulations, vaccine delivery, antiviral strategies, pathogen sensors and ligands, viral immunology, clinical trials, and human immunological monitoring.
Biography Updated on 13 April 2011